PCR & Real-time PCR Molecular Diagnostics Market Size [2031]
PCR & Real-time PCR Molecular Diagnostics Market Size [2031]
Segments - PCR & Real-time PCR Molecular Diagnostics Market by Product Type (Consumables, Instruments, Reagents, and Software), Application (Infectious Disease Testing, Oncology Testing, and Other Applications), End-user (Diagnostics Laboratories, Hospitals, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-6099
| 4.6 Rating
| 56 Reviews
| 191 Pages
| Format :
Report Description
PCR & Real-time PCR Molecular Diagnostics Market Outlook 2031
The global PCR & real-time PCR molecular diagnostics market size was USD 4.4 Billion in 2022 and is likely to reach USD 6.8 Billion by 2031, expanding at a CAGR of 4% during 2023–2031. The market growth is attributed to the increasing availability of diagnostic measures.
Growing advances in genomics and stem cell research is projected to boost the market during the assessment period. A significant number of diagnostic tests for the detection of infectious as well as non-infectious diseases are being developed. One of the most effective versions of these tests include the PCR rests. These tests can accurately detect the presence of pathogens and are being widely used, thus fueling market growth. For instance,
-
According to a May 2021 report published by the National Institutes of Health, the development of diagnostic tests based on the process of RNA amplification known as quantitative real-time polymerase chain reaction (qPCR) is proven to be the gold standard for PCR testing. It boasts an accuracy rate of almost 100%.
The rapid advancements in medical science and technology have led to easy access to PCR tests. A growing number of individuals, especially in middle and high-income countries have easy access to PCR diagnostic tests. Today, most medical centers and clinics have access to most forms of PCR tests to facilitate the early treatment of diseases. This is anticipated to impel the market during the projection period.
The COVID-19 pandemic propelled market growth owing to the urgency of diagnostic measures. Due to the widespread proliferation of the virus and the severity of the illness, governments worldwide dedicated their resources to developing highly accurate diagnostic measures, fueling market growth. Although the COVID-19 RT-PCR test had its pitfalls, it was distributed to all corners of the world to provide effective and efficient containment measures for the virus.
Impact of Artificial Intelligence (AI) in PCR & Real-time PCR Molecular Diagnostics Market
The advent of Artificial Intelligence (AI) is projected to augment the market considerably, owing to quicker and more accurate diagnostics. AI-based deep learning technologies display a considerable rate of accuracy as compared to conventional PCR tests. These technologies effectively and accurately examine large amounts of datasets, producing quick and highly accurate results. For instance.
-
According to a January 2022 journal article “The application of a deep learning system developed to reduce the time for RT-PCR in COVID-19 detection”, AI-based deep learning algorithms registered an accuracy rate of 90%—92% for the detection of the COVID-19 virus.
PCR & Real-time PCR Molecular Diagnostics Market Dynamics
Drivers
Growing prevalence of infectious diseases is expected to propel the market over the forecast period. Owing to the rampant population growth over the last few decades, the spread of bacterial and viral illnesses has proliferated considerably, thereby propelling market growth. The boost in the market is especially visible during the post-pandemic period where multiple renditions of real-time PCR tests were developed for the quick and accurate diagnosis of the virus. These factors are likely to impel the market during the assessment period.
Restraints
High cost associated with the development of real-time PCR tests is a potential setback for market growth. Owing to the lack of established medical infrastructures in low-income countries, there is a lack of access to most PCR tests. Additionally, the absence of skilled medical professionals and researchers in these regions also poses a hurdle for the market.
Emerging Opportunities
Emerging technologies in PCR testing are projected to streamline the market considerably. The use of testing technologies is projected to speed up the process of testing. These tests result in quicker diagnoses and are proven to be especially effective in impeding the spread of highly infectious diseases that require immediate isolation. This includes the COVID-19 virus. For instance,
-
According to an October 2021 report published by Science Direct, DNA modification technology, CRISPR has proven to be highly effective and effective in the detection of the SARS-CoV-2 RNA. CRISPR-based testing holds an accuracy rate of 71.4%—98.5%.
Scope of the PCR & Real-time PCR Molecular Diagnostics Market Report
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
PCR & Real-time PCR Molecular Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2020–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Product Type (Consumables, Instruments, Reagents, and Software), Application (Infectious Disease Testing, Oncology Testing, and Other Applications), and End-user (Diagnostics Laboratories, Hospitals, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott; BD; bioMérieux SA; Bio-Rad Laboratories, Inc.; Danaher Corporation; Exact Sciences Corporation.; F. Hoffmann-La Roche; Grifols, S.A.; Hologic; QIAGEN; S. A. Pharmachem Pvt. Ltd.; Seegene Inc.; and Thermo Fisher Scientific Inc. |
Market Segment Insights
Product Type Segment Analysis
Based on product type, the PCR & real-time PCR molecular diagnostics market is divided into consumables, instruments, reagents, and software. The software segment is expected to dominate the market during the projection period owing to the rapid technological advancements and digitization of PCR testing. Due to the advent of microfluid systems, PCR tests are being increasingly miniaturized. This miniaturization of various testing software is projected to lead to the easy availability and low cost of different types of PCR tests, thereby fueling segment growth.
Application Segment Analysis
On the basis of application, the global market is segregated into infectious disease testing, oncology testing, and other applications. The oncology testing segment is projected to dominate the market during the forecast period owing to the worldwide proliferation of cancer. Rampant growth in various cancers has been observed due to increasingly unhealthy lifestyles and rising life expectancy. This has resulted in a growing demand for PCR-based tests, thereby boosting segment growth.
In recent years, the infectious disease testing segment has also shown considerable growth, owing to the rampant proliferation of pandemics such as COVID-19. Growing importance is being placed on more effective diagnosis, thereby fueling segment growth. Additionally, the growing prevalence of zoonotic infections such as dengue and malaria is projected to propel the segment in the years to come.
End-user Segment Analysis
On the basis of end-users, the market is segmented into diagnostics laboratories, hospitals, and others. The hospital segment is expected to register a robust growth rate during the forecast period owing to easy access to modern medical equipment. Due to increased funding and medical infrastructure allocated to hospitals, they have the required access to the most modern and effective versions of PCR tests. This factor is expected to impel the segment over the coming years.
Regional Outlook
In terms of region, the global PCR & real-time PCR molecular diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period owing to the increased incidences of diseases as well as the easy access to medical infrastructure.
The growth of the elderly, and vulnerable populations as well as the rise in unhealthy lifestyle habits is leading to higher rates of illnesses. This is considered to be the major factor fueling market growth. Additionally, easy access to advanced medical infrastructure allows individuals access to a multitude of real-time PCR tests further boosting market growth.
The Asia Pacific region is projected to register a considerable CAGR over the forecast period owing to the large population of the region. The high population numbers as well as density, enable the proliferation of numerous infectious diseases, thereby giving rise to the demand for PCR tests. The difficulty faced by governments in implementing containment measures in largely populated regions further amplified the need for testing measures. These problems are especially apparent in the densely populated regions of China and India, further fueling market growth.
Segments
The PCR & real-time PCR molecular diagnostics market has been segmented on the basis of
Product Type
- Consumables
- Instruments
- Reagents
- Software
Application
- Infectious Disease Testing
- Oncology Testing
- Other Applications
End-user
- Diagnostics Laboratories
- Hospitals
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott
- BD
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Exact Sciences Corporation.
- F. Hoffmann-La Roche
- Grifols, S.A.
- Hologic
- QIAGEN
- S. A. Pharmachem Pvt. Ltd.
- Seegene Inc.
- Thermo Fisher Scientific Inc.
Competitive Landscape
Key players competing in the global PCR & real-time PCR molecular diagnostics market are Abbott; BD; bioMérieux, Bio-Rad Laboratories, Inc.; Danaher Corporation; Exact Sciences Corporation.; Roche; Grifols, S.A.; Hologic; QIAGEN; S. A. Pharmachem Pvt. Ltd.; Seegene Inc.; and Thermo Fisher Scientific Inc.
These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide. For instance,
-
In July 2021, Abbott launched the COVID-19 antigen self-test in India. This test is used to detect the presence of the SARS-CoV-2 virus in asymptomatic carriers. This test is projected to reduce the burden on healthcare sectors and will also make COVID-19 antigen tests easily accessible.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. PCR & Real-time PCR Molecular Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. PCR & Real-time PCR Molecular Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. PCR & Real-time PCR Molecular Diagnostics Market - Supply Chain
4.5. Global PCR & Real-time PCR Molecular Diagnostics Market Forecast
4.5.1. PCR & Real-time PCR Molecular Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. PCR & Real-time PCR Molecular Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. PCR & Real-time PCR Molecular Diagnostics Market Absolute $ Opportunity
5. Global PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Applications
5.3.1. Infectious Disease Testing
5.3.2. Oncology Testing
5.3.3. Other Applications
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by End Users
6.3.1. Diagnostics Laboratories
6.3.2. Hospitals
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global PCR & Real-time PCR Molecular Diagnostics Demand Share Forecast, 2019-2026
8. North America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Applications
8.4.1. Infectious Disease Testing
8.4.2. Oncology Testing
8.4.3. Other Applications
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by End Users
8.7.1. Diagnostics Laboratories
8.7.2. Hospitals
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America PCR & Real-time PCR Molecular Diagnostics Demand Share Forecast, 2019-2026
9. Latin America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Applications
9.4.1. Infectious Disease Testing
9.4.2. Oncology Testing
9.4.3. Other Applications
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by End Users
9.7.1. Diagnostics Laboratories
9.7.2. Hospitals
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America PCR & Real-time PCR Molecular Diagnostics Demand Share Forecast, 2019-2026
10. Europe PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Applications
10.4.1. Infectious Disease Testing
10.4.2. Oncology Testing
10.4.3. Other Applications
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by End Users
10.7.1. Diagnostics Laboratories
10.7.2. Hospitals
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe PCR & Real-time PCR Molecular Diagnostics Demand Share Forecast, 2019-2026
11. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Applications
11.4.1. Infectious Disease Testing
11.4.2. Oncology Testing
11.4.3. Other Applications
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by End Users
11.7.1. Diagnostics Laboratories
11.7.2. Hospitals
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Demand Share Forecast, 2019-2026
12. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by Applications
12.4.1. Infectious Disease Testing
12.4.2. Oncology Testing
12.4.3. Other Applications
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Size and Volume Forecast by End Users
12.7.1. Diagnostics Laboratories
12.7.2. Hospitals
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global PCR & Real-time PCR Molecular Diagnostics Market: Market Share Analysis
13.2. PCR & Real-time PCR Molecular Diagnostics Distributors and Customers
13.3. PCR & Real-time PCR Molecular Diagnostics Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Abbott
13.4.2. BD
13.4.3. bioMérieux SA
13.4.4. Bio-Rad Laboratories, Inc.
13.4.5. Danaher Corporation
13.4.6. Exact Sciences Corporation.
13.4.7. F. Hoffmann-La Roche
13.4.8. Grifols, S.A.
13.4.9. Hologic
13.4.10. QIAGEN
13.4.11. S. A. Pharmachem Pvt. Ltd.
13.4.12. Seegene Inc.
13.4.13. Thermo Fisher Scientific Inc.
Methodology
Related Reports
Some other reports from this category!
Our Clients
